{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:36:12Z","timestamp":1782408972538,"version":"3.54.5"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["TFU 127880"],"award-info":[{"award-number":["TFU 127880"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Donors with an increased risk of transmitting human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>), hepatitis B virus (<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>), or hepatitis C virus (<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>) (increased risk donors [<jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s]) are a potential source of organs for transplant. Organs from <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s can be utilized with appropriate recipient consent and post\u2010transplant follow\u2010up. We reviewed the characteristics and utilization of <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s in our Organ Procurement Organization (<jats:styled-content style=\"fixed-case\">OPO<\/jats:styled-content>) over a 2\u2010year period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Donor information from April 1, 2013 to March 31, 2015 was obtained through the <jats:styled-content style=\"fixed-case\">OPO<\/jats:styled-content> database. Only consented donors were included. Donors were categorized as <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s according to Health Canada\/Canadian Standards Association (<jats:styled-content style=\"fixed-case\">CSA<\/jats:styled-content>) criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 494 potential donors were identified, of which 92 (18.6%) were <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s. Of these, at least one organ was transplanted from 76 (82.6%). Risk factors for <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s included injection drug user (<jats:styled-content style=\"fixed-case\">IDU<\/jats:styled-content>) (12%), men having sex with men (<jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content>) (7%), commercial sex worker (<jats:styled-content style=\"fixed-case\">CSW<\/jats:styled-content>) (4%), and incarceration (24%). Fifty\u2010nine percent (253\/429) of <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content> organs were utilized. The most frequently used organ was kidney, followed by liver. Median number of organs recovered per <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content> was 3 (interquartile range: 2\u20105). Nucleic acid testing (<jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content>) was performed in 18.5% (17\/92) of <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s. Reasons for <jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content> were <jats:styled-content style=\"fixed-case\">IDU<\/jats:styled-content> (n\u00a0=\u00a02), <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> (n\u00a0=\u00a02), <jats:styled-content style=\"fixed-case\">CSW<\/jats:styled-content> (n\u00a0=\u00a02), and previous incarceration (n\u00a0=\u00a07). Organ utilization from donors that had <jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content> was similar to donors who did not (94% vs 80%, <jats:italic>P<\/jats:italic>\u00a0=\u00a0.29). Follow\u2010up <jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content> was done in &lt;5% of recipients from <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our cohort, <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content>s comprised a significant proportion of donors. Utilization of <jats:styled-content style=\"fixed-case\">IRD<\/jats:styled-content> organs occurred at a significant rate regardless of pre\u2010transplant <jats:styled-content style=\"fixed-case\">NAT<\/jats:styled-content>. These data suggest that multiple factors contribute to the perception of infectious risk from such organs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12785","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T14:32:34Z","timestamp":1507213954000},"source":"Crossref","is-referenced-by-count":9,"title":["Organ utilization from increased infectious risk donors: An observational study"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-7285","authenticated-orcid":false,"given":"Arnaud G.","family":"L'Huillier","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Humar","sequence":"additional","affiliation":[{"name":"Multi\u2010Organ Transplant Program University of Heath Network  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Payne","sequence":"additional","affiliation":[{"name":"Trillium Gift of Life Network  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Kumar","sequence":"additional","affiliation":[{"name":"Multi\u2010Organ Transplant Program University of Heath Network  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Organ Procurement and Transplantation Network.Transplant by Donor Type.2017. Available from:https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/#;. Accessed October 11 2017."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03518.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/TP.0000000000000251","article-title":"Guidance on the use of increased infectious risk donors for organ transplantation","volume":"98","author":"Blydt\u2010Hansen T","year":"2014","journal-title":"Transplantation"},{"key":"e_1_2_7_5_1","first-page":"59","volume-title":"Cells, tissues, organs for transplantation: General requirements","author":"Canadian Standards Association and Standards Council of Canada","year":"2012"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12386"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21534"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03597.x"},{"key":"e_1_2_7_10_1","article-title":"Four transplant recipients contract HIV","author":"Grady D","year":"2007","journal-title":"New York Times"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02012.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283094ba3"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02593.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2009.00997.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02782.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.05.065"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2016.01.008"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2015.12.062"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12761"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.06.005"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01769.x"},{"key":"e_1_2_7_22_1","unstructured":"Canadian Standards Association and Standards Council of Canada.Canadian cells tissues and organ regulations. Exceptional distribution (section 40\u201042)."},{"key":"e_1_2_7_23_1","unstructured":"Canadian Institute for Health Information.e\u2010Statistics Report on Transplant Waiting List and Donor Statistics. 2014 summary statistics January 1 to December 31 2014. 2016. Available from:https:\/\/www.cihi.ca\/en\/types-of-care\/specialized-services\/organ-replacements\/e-statistics-report-on-transplant-waiting-li-7. Accessed February 26 2017."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12206"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02522.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03460.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03329.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.011"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12260"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000843"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12121"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T03:07:22Z","timestamp":1696043242000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1111\/tid.12785"],"URL":"https:\/\/doi.org\/10.1111\/tid.12785","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]},"article-number":"e12785"}}